Skip to main content
Rafael Holdings, Inc. logo

Rafael Holdings, Inc. — Investor Relations & Filings

Ticker · RFL ISIN · US75062C1009 US Professional, scientific and technical activities
Open in API
Filings indexed 393 across all filing types
Latest filing 2022-08-01 Regulatory Filings
Country US United States of America
Listing US RFL

About Rafael Holdings, Inc.

https://rafaelholdings.com

Rafael Holdings, Inc. is a clinical-stage biotechnology company that invests in and develops therapies for difficult-to-treat diseases. The company holds interests in early-stage and clinical pharmaceutical entities, with a primary focus on novel cancer therapeutics aimed at improving and extending the lives of patients. Following a merger with Cyclo Therapeutics, Rafael Holdings is also advancing a potential breakthrough treatment for Niemann-Pick Type C1, a rare genetic disorder.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A, which is a Current Report filed pursuant to the Securities Exchange Act of 1934. It reports on the entry into a material definitive agreement related to the sale of a property owned by the company. The content focuses on updates to a contract of sale, escrow deposits, and closing date extensions. There are no financial statements or comprehensive financial data presented, nor is this an annual or quarterly report. The document is a regulatory announcement about a material event, specifically a contract amendment and sale process update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-08-01 English
SCHEDULE 13D
Major Shareholding Notification
2022-07-18 English
FORM 3 SUBMISSION
Director's Dealing
2022-07-18 English
FORM 4 SUBMISSION
Director's Dealing
2022-07-07 English
AMENDMENT NO. 1 TO FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details an unregistered sale of equity securities by Rafael Holdings, Inc., specifically the sale of Class B common stock shares to an affiliated entity. The content focuses on a capital transaction involving stock issuance and pricing details. There is no indication of it being an annual or quarterly report, audit report, earnings release, or other types of filings. The primary subject is a financing activity related to equity securities. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is 4411 characters, which is consistent with a detailed but not overly lengthy report typical for such filings. Confidence is high given the clear description of the transaction and the form type (8-K/A) which is commonly used for such disclosures.
2022-07-06 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a Stock Purchase Agreement involving the sale of shares by the company to an affiliated entity, including details about the price and approval. This is an update on a financing or capital transaction rather than a full financial report or earnings release. The document length is 4200 characters, which is relatively short and consistent with an 8-K filing announcing a capital transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-07-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.